Global Rehabilitation Equipment Market 2019 Industry Trends, Growth Forecast

According to the new market research report “Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) — Forecast”, published by MarketsandMarkets™, the global Rehabilitation Equipment Market is expected to reach 14.91 Billion, at a CAGR of 8.6% during the forecast period.

The Research Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The growth of this market is mainly driven by factors such as growing incidence of disabilities resulting from non-communicable diseases, favorable healthcare reforms, and rapid growth in the geriatric population coupled with the rising prevalence of chronic diseases. However, a high cost & maintenance expense of rehabilitation equipment is the key factor that is expected to restrain the growth of this market to a certain extent.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194775519

In this report, the Rehabilitation Equipment Market has been segmented on the basis of type, application, end user, and region. Based on type, the Rehabilitation Equipment Market is segmented into mobility equipment, body support devices, exercise equipment, and daily living aids. In 2016, the daily living aids segment accounted for the largest share of the market.

Browse and in-depth TOC on “Rehabilitation Equipment Market”

154 — Tables

31 — Figures

162 — Pages

On the basis of the end user, the Rehabilitation Equipment Market is segmented into hospitals & clinics, rehabilitation centers, physiotherapy centers, and home care settings. In 2016, the hospitals & clinics segment accounted for the largest share of the Rehabilitation Equipment Market. This can be attributed to factors such as higher quality of treatment provided in hospitals and clinics, as opposed to other end-user segments, increasing sports injuries, the growth of the disabled and aged populations, and supportive reimbursement policies for hospital treatment.

Based on the region, the Rehabilitation Equipment Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, Europe dominated the market, followed by North America. Factors such as supportive government initiatives for safe patient handling, growth in the geriatric population, and the presence of a large number of players in Europe are driving the growth of the European Rehabilitation Equipment Market.

Read a Press-Release on “Rehab Equipment Market”

https://www.marketsandmarkets.com/PressReleases/rehabilitation-equipment.asp

The Rehabilitation Equipment Market is fragmented in nature with several big and emerging players. This market is dominated by key players such as Invacare Corporation (U.S.), Medline Industries, Inc. (U.S.), Dynatronics Corporation (U.S.), Drive DeVilbiss Healthcare (U.S.), Changzhou Qian Jing Rehabilitation Co., Ltd. (China), Carex Health Brands (U.S.), Roma Medical (U.K.), Caremax Rehabilitation Equipment Co. Ltd. (China), GF Health Products, Inc. (U.S.), and HEMC (Hospital Equipment Manufacturing Company) (India).

Veterinary Chemistry Analyzer Market Revenue, Demand, Opportunity, Segment and Key Trends 2019

According to the new market research report “Veterinary Chemistry Analyzer Market by Product (Chemistry Analyzer, Glucometer, Consumables (Panel, Test Strip, Reagent)) Application (Blood Chemistry Analysis, Urinalysis, Glucose Monitoring) & Animal (Companion & Livestock) — Global Forecast”,published by MarketsandMarkets™, the Global Veterinary Chemistry Analyzer Market is estimated to grow at a CAGR of 8.7%, to reach USD 1,205.2 Million.

The growth in this market is majorly attributed to factors such as growing livestock and companion animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, raising awareness about zoonotic diseases, and an increasing number of veterinary practitioners across the globe.

Read a Press Release on “Veterinary Chemistry Analyzer Market”:

https://www.marketsandmarkets.com/PressReleases/veterinary-chemistry-analyzer.asp

The Global Veterinary Chemistry Analyzer Market is segmented on the basis of product, application, animal type, and region. On the basis of product, this market is segmented into instruments and consumables (panels, kits, test strips, and reagents). In 2016, the consumables segment accounted for the largest share of the global Veterinary Chemistry Analyzer Market. It is expected to register the highest growth during the forecast period. The high growth of this segment is mainly attributed to the increased adoption of the pre-loaded multiple reagent panels and pre-loaded single slide reagent panels by the end users.

Browse and in-depth TOC on “Veterinary Chemistry Analyzer Market”

206 — Tables

24 — Figures

250 — Pages

On the basis of application, the market is categorized into blood chemistry analysis, urinalysis, glucose monitoring, and blood gas-electrolyte analysis. The blood chemistry analysis segment accounted for the largest share, while the glucose-monitoring segment is expected to witness the highest growth during the forecast period. The Veterinary Chemistry Analyzer Market is further segmented, on the basis of animal type, into companion animals and livestock. The companion animal segment accounted for the largest share of the market. This segment is also expected to register the highest growth during the forecast period.

The report also provides a detailed geographic analysis of the Veterinary Chemistry Analyzer Market covering developed and emerging economies. The developed market includes the U.S., Canada, Germany, the U.K., France, Italy, Spain, and Japan while the emerging market includes China, India, and Latin America. The U.S. attributed the largest share of the developed market owing to its well-established animal healthcare systems. The large share of this regional market segment is driven by increasing demand for animal-derived food products, rising animal healthcare expenditure, growing animal population, and raising awareness about zoonotic diseases.

Some of the prominent players in this market are IDEXX Laboratories, Inc. (U.S.), Abaxis, Inc. (U.S.), Heska Corporation (U.S.), Randox Laboratories Ltd. (U.K.), ARKRAY, Inc. (Japan), Eurolyser Diagnostica GmbH (Austria), Alfa Wassermann Inc. (U.S.), DiaSys Diagnostic Systems, USA, LLC (U.S.), Diconex SA (Argentina), Chengdu Seamaty Technology Co., Ltd.(China), Biochemical Systems International Srl (Italy), ELITechGroup (France), and URIT Medical Electronic Group Co. Ltd (China).

Know more about key industry players:

https://www.marketsandmarkets.com/ResearchInsight/veterinary-chemistry-analyzer-market.asp

Global Antinuclear Antibody Test Market 2019: Opportunities, Challenges, and Forecast

The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.

Don’t miss out on business opportunities in Antinuclear Antibody Test Market

The Global Antinuclear Antibody Test Market is expected to reach USD 1,476.1 Million, at a CAGR of 12.4%

The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.

This report segments this ANA testing market based on products, diseases, techniques, end users, and regions. In the product's market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.

Browse and in-depth TOC on “Antinuclear Antibody Test Market”

73 — Tables

102 — Figures

166 — Pages

Based on techniques, the Antinuclear Antibody Test Market is segmented into three broad segment, namely, enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market owing to expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.

The Antinuclear Antibody Test Market’s end-user segments in this market include clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share in 2016, primarily due to the rising healthcare spending which has resulted in a growth in use of ANA testing products in hospitals. Based on region, the global Antinuclear Antibody Test Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising geriatric population and increasing prevalence of autoimmune diseases.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=218189007

Key players in the Antinuclear Antibody Test Market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Needle-Free Injection System Market Professional Survey Report 2019

According to Latest Market research report Published by MarketsandMarkets the “Needle-Free Injection System Market Size, Share, Demand and Growth Analysis, forecast” the Global Market is expected to reach $ 20.17 billion, at a CAGR of 15.5%

Growth in this market is mainly driven by the growing prevalence of the chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

key players operating in the Global Needle-Free Injection System Market;

Companies are focusing on adopting organic as well as inorganic growth strategies such as acquisition, agreements, collaboration, expansion, product upgrades, partnerships, and others (approvals and certifications) to synergistically offer advanced needle-free injection solutions in the market

Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Major Drivers Impacting the Needle-Free Injection System Market;

· Growing Prevalence of Chronic Diseases

· Increasing Incidence of Communicable Diseases Due to Needlestick Injuries

· Rise in Demand for Self-Injection Devices

· Rising Demand for Biosimilars and Vaccination

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Global Needle-Free Injection System Market Segmentation:

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

Global Needle-Free Injection System Market, by type of Medication

• Liquid-based needle-free injectors
• Powder-based needle-free injectors
• Projectile/depot-based needle-free injectors

Global Needle-Free Injection System Market, by Application

• Vaccine Needle-free delivery
• Insulin Needle-free delivery
• Pain Management Needle-free delivery
• Oncology Needle-free delivery

Microservices in Healthcare Market Professional Survey Report 2019

The Global Microservices in Healthcare Market is projected to reach USD 343.3 million, at a CAGR of 21.3%

The research report on “Microservices in Healthcare Market by Component (Platform, Services (Consulting, Integration, Training, Support, Maintenance)), Delivery (Cloud, Hybrid, Private, On-premise), End User (Health care Provider, Payer, Life Science) — Global Forecast to 2023”

Download PDF (Delivery — Cloud ):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119908608

Microservices in Healthcare Market segmentation:

· by Component

· by Delivery Model

· by End-user

· by Region

On the basis of end user, the microservices in healthcare market is segmented into healthcare payers, healthcare providers, life science organizations, and clinical laboratories. The healthcare providers segment is expected to account for the largest share of the overall market in 2018. Government initiatives that help providers gain incentives on the adoption of EHRs and the implementation of integration and connectivity solutions are driving the adoption of microservices architecture solutions among healthcare providers.

The Objectives of this study are as follows:

• To define, describe, and forecast the global microservices in the healthcare market by deployment model, component, end user, and region
• To provide detailed information about the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)

The Major Players Operating in the Microservices in Healthcare Market:

The microservices in healthcare market is marked by the presence of several big and small players. Prominent players in this market include AWS (US), CA Technologies (US), Microsoft (US), Salesforce (US), Pivotal Software (US), Infosys (India), IBM (US), NGINX (US), Oracle Corporation (US), and Syntel (US).

Microsoft is one of the leading providers of microservices. The company caters to the microservices market through the Azure platform. The company’s Service Fabric microservices platform helps enterprises reduce their production time and enable faster application delivery with minimal CAPEX and OPEX. Microsoft focuses on strengthening its R&D efforts to reinvent business productivity, build intelligent cloud platforms, and create personal computing solutions. In June 2018, the company launched Azure Kubernetes Service (AKS) and, in April 2018, the company updated its Service Fabric 6.2. The company also provides its users with economical and convenient products that are integrated with the latest technological solutions and services. Microsoft’s strategy requires it to continuously invest in data centers and other infrastructures to support devices and services.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=119908608

Geographical Detailed Analysis for Microservices in Healthcare Market:

Geographically, the microservices in healthcare market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the market in 2018.

The large share of North America in the global microservices in healthcare market can be attributed to the growing focus on improving the overall efficiency of healthcare organizations and greater product and service availability in the region.

Embolic Protection Devices Market size, Demand, Analysis and Opportunity Forecast

The Growth in this Embolic Protection Devices Market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, the launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures.

The report “Embolic Protection Device Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) — Global Forecast to 2023”

The global market is projected to reach $ 604.9 million by 2023, at a CAGR of 8.3% during the forecast period

By indication, the percutaneous coronary intervention segment accounted for the largest market share in 2017

On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. In 2017, the percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803

Global Embolic Protection Device Market, By Application

• Cardiovascular Diseases
• Neurovascular Diseases
• Peripheral Diseases

Hospitals are expected to be the largest end users of embolic protection devices during the forecast period

The major end users of embolic protection devices market are hospitals and ambulatory surgical centers. The hospital segment is expected to grow at the highest CAGR during the forecast period. The market for this segment is mainly driven by factors such as the growing number of angioplasty procedures performed in hospitals, rising incidence of chronic vascular diseases, favorable reimbursement scenario in developed countries, growing number of hospitals, and increasing government initiatives to provide quality treatment for cardiovascular diseases.

Geographic Analysis

• Further breakdown of the Rest of Asia Pacific embolic protection devices market into South Korea, Australia, New Zealand, and others
• Further breakdown of the Rest of Europe market into Belgium, Russia, the Netherlands, Switzerland, and others
• Further breakdown of the Rest of Latin America market into Argentina, Colombia, Chile, and others

North America dominated the market. The rising geriatric population and prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and the presence of a large number of medical device product manufacturers are driving the growth of the embolic protection device market in North America.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803

The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

Thawing System Market Professional Survey Report 2019

The Thawing System Market covers devices that are used to unfreeze and defrost biological samples such as blood and blood products, semen, ovum, embryos, and human tissues.

Factors driving the growth of this market include technologically advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing the use of thawed cells in the treatment of cancers and diabetes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185341188

Thawing System Market segmentation:

· based on the type

· based on sample type

· based on the end user

· based on regions

The Major Players Operating in the Thawing System Market:

Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US).

The objectives of this study are as follows:

• To define, describe, and forecast the thawing system market on the basis of type, sample type, end user, and region
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
• To identify the micro-markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
• To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the thawing system market

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=185341188

Thawing System Market by End User:

• Blood Banks & Transfusion Centers
• Hospitals & Diagnostic Laboratories
• Cord Blood & Stem Cell Banks
• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies
• Tissue Banks

Geographical Detailed Analysis for Thawing System Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the thawing system market. This is attributed to factors such as improvements in blood bank and biobank infrastructure, increasing research activities in regenerative medicine as well as cell and gene therapy, growing interest in personalized medicine and biomarker discovery, increasing number of biotechnology and pharmaceutical companies, and increasing government funding.